Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advanced glucose control strategies leveraging Raman spectroscopy for optimized mammalian cell culture manufacturing.

Biotechnology progress·2026

Same author

Firm, Yellow, and Now Fluid-Filled!

Clinical and experimental dermatology·2026

Same author

Predicting gene essentiality and drug response from preclinical perturbation screens with layered ensemble of autoencoders and predictors.

Scientific reports·2026

Same author

Capacitance Technology Enables Automated Feeding, Improved Expansion, and Higher Throughput of CAR-T Cell Stirred-Tank Bioreactor Cultures.

Biotechnology journal·2026

Same author

A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO.

mAbs·2026

Same author

Multimodal Chromatography in the Downstream Processing of mAb-Based Products: Mechanisms, Strategies, and Applications.

Biotechnology and bioengineering·2026

Search research articles

Related Experiment Video

Updated: Jul 26, 2025

Automated Gel Size Selection to Improve the Quality of Next-generation Sequencing Libraries Prepared from Environmental Water Samples

Automated Gel Size Selection to Improve the Quality of Next-generation Sequencing Libraries Prepared from Environmental Water Samples

Published on: April 17, 2015

Next-generation cell line selection methodology leveraging data lakes, natural language generation and advanced data

Stephen Goldrick¹, Haneen Alosert¹, Clare Lovelady²

¹Department of Biochemical Engineering, University College London, London, United Kingdom.

Frontiers in Bioengineering and Biotechnology

|June 21, 2023

Summary

A new cell line development (CLD) methodology uses digitalization, a manufacturability index (MI), and machine learning for autonomous, data-driven clone selection. This approach improves biopharmaceutical development by identifying risks and optimizing processes for better product quality.

Keywords:

Industry 4.0 cell line development data analytics machine learning natural language generation

More Related Videos

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Related Experiment Videos

Last Updated: Jul 26, 2025

Automated Gel Size Selection to Improve the Quality of Next-generation Sequencing Libraries Prepared from Environmental Water Samples

Automated Gel Size Selection to Improve the Quality of Next-generation Sequencing Libraries Prepared from Environmental Water Samples

Published on: April 17, 2015

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Area of Science:

Biopharmaceutical Development
Biotechnology
Process Engineering

Background:

Cell line development is critical in biopharmaceutical manufacturing.
Incomplete clone characterization causes project delays and impacts commercial success.
Current methods may miss crucial process-related quality issues.

Purpose of the Study:

To introduce a novel, autonomous, data-driven cell line development (CLD) methodology.
To enhance lead clone selection through digitalization, advanced analytics, and automated reporting.
To address limitations in conventional cell line development processes.

Main Methods:

Digitalization of process data into a structured data lake.
Calculation of a cell line manufacturability index (MI) for clone performance.
Application of machine learning (ML) to identify process risks and critical quality attributes (CQAs).
Automated report generation using natural language generation (NLG).

Main Results:

The CLD methodology successfully selected a lead clone for a recombinant Chinese hamster ovary (CHO) cell line.
It identified sub-optimal conditions affecting trisulfide bond (TSB) concentration, a known product quality issue.
The approach revealed quality issues missed by conventional methods.

Conclusions:

The CLD methodology, aligned with Industry 4.0 principles, enhances decision-making in biopharmaceutical development.
Digitalization, data lakes, predictive analytics, and autonomous reporting are key benefits.
This novel approach leads to more informed and efficient cell line selection and process optimization.